Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Response.
Anu SharmaSumit K SubudhiJorge BlandoLuis VenceJennifer WargoJames P AllisonAntoni RibasPadmanee SharmaPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)